My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2015
POLICY AND ADVOCACY
IDSA and HIVMA “Rally for Medical Research”
IDSA and HIVMA participated in the 3rd annual “Rally for Medical Research” Capitol Hill Day event on Sept. 17. The Rally for Medical Research is a collaborative effort supported by 300 organizations representing a broad spectrum of diseases. Hundreds of partnering organization representatives from across the nation deployed across the Hill to urge Congress to invest in the National Institutes of Health for the health and economic security of our nation. Our messages were amplified by a social media effort targeting members of Congress and the general public.



< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
CDC Investigates Multistate Outbreak of Listeriosis Linked to Soft Cheeses
POLICY AND ADVOCACY
IDSA Leaders Appointed to New Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
IDSA and HIVMA “Rally for Medical Research”
S-FAR Holds Strategy Meeting with over 50 Partner Organizations
GLOBAL ID
Science Speaks Reports on New HIV and TB Resources
EDUCATION AND RESOURCES
IDSA Education and Research Foundation to Host Donors’ Lounge at IDWeek 2015
Thank You—We Couldn't Have Done it Without You
IDSA Education and Research Foundation Announces New Award in Memory of Robert C. Moellering, MD, FIDSA
ASP Announces Accreditation Seminar
YOU AND YOUR COLLEAGUES
Member Report
FROM THE PRESIDENT
From Ebola, Antibiotic Resistance and ABIM to Strategic Planning…A Year in Review
TOP STORIES
Bipartisan Antibiotic and Diagnostic Tax Credit Bill Introduced in Congress
Drug Company Reverses 5,000% Increase in Drug Price
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.